Macrogenics (MGNX) Other Working Capital Changes (2012 - 2026)
Macrogenics' (MGNX) quarterly Other Working Capital Changes came in at -$324000.0 in Q1 2026, down 6580.0% year-on-year from $5000.0 in Q1 2025, and down 214.89% on a QoQ basis from $282000.0 in Q4 2025.
Macrogenics (MGNX) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 9 years of Other Working Capital Changes data on file, last reported at -$324000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 6580.0% year-over-year to -$324000.0 in Q1 2026; TTM through Mar 2026 was -$5.7 million, a 23.98% increase from a year earlier, with the FY2025 full-year figure at -$5.4 million, up 42.66% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$324000.0, down from $282000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for MGNX reached as high as $14.0 million in Q4 2022 and fell as low as -$6.5 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged $989142.9 across 5 years, with a median of -$70500.0 in 2024.
- Across the five-year window, Other Working Capital Changes surged 1751.54% in 2022 and slumped 6580.0% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at $57.3 million in 2022, then plunged by 78.8% to $12.1 million in 2023, then tumbled by 178.54% to -$9.5 million in 2024, then surged by 102.96% to $282000.0 in 2025, then sank by 214.89% to -$324000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$324000.0 in Q1 2026, $282000.0 in Q4 2025, and -$5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -374,000.00 |
| Mar 31, 2026 | -374,000.00 |
| Mar 31, 2026 | -374,000.00 |
| Dec 31, 2025 | 164,000.00 |
| Dec 31, 2025 | 164,000.00 |
| Dec 31, 2025 | 164,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Mar 31, 2025 | -66,000.00 |
| Mar 31, 2025 | -66,000.00 |
| Mar 31, 2025 | -66,000.00 |
| Dec 31, 2024 | 370,000.00 |
| Dec 31, 2024 | 370,000.00 |
| Dec 31, 2024 | 370,000.00 |
| Jun 30, 2024 | -125,000.00 |
| Jun 30, 2024 | -125,000.00 |